[Dobutamine stress echocardiography in patients with hypertrophic cardiomyopathy]

Area of Science:

• Cardiology
• Medical Imaging
• Pharmacology

Background:

• Hypertrophic cardiomyopathy (HCM) is a complex condition characterized by left ventricular hypertrophy.
• Assessing obstruction in HCM, particularly dynamic obstruction, is crucial for patient management.
• Differentiating resting obstruction from provokable obstruction is key for accurate diagnosis and treatment strategies.

Purpose of the Study:

• To evaluate the safety and efficiency of dobutamine stress echocardiography (DSE) in patients with HCM.
• To compare provokable obstruction with resting obstruction in HCM patients.
• To determine the diagnostic utility of DSE for detecting obstruction in HCM.

Main Methods:

• Dobutamine stress echocardiography was performed on 22 patients with HCM and low resting outflow tract pressure gradient (LVOTPG < 50 mm Hg).
• Dobutamine was administered incrementally up to 20 microg x min(-1) x kg(-1).
• Echocardiography assessed left ventricular outflow tract pressure gradient (LVOTPG) at rest and peak stress.

Main Results:

• Dobutamine stress echocardiography was safe in the studied HCM population.
• Sixteen out of 22 patients showed positive stress test results, indicating provokable obstruction.
• Patients with provokable obstruction had fewer systolic anterior motion (SAM) positive cases and a higher proportion of Maron II classification (50%).

Conclusions:

• Dobutamine stress echocardiography is a safe and sensitive tool for detecting obstruction in hypertrophic cardiomyopathy.
• DSE effectively distinguishes between provokable and resting obstruction.
• Provokable obstruction in HCM is associated with specific echocardiographic findings, including reduced SAM and a higher prevalence of Maron II.